Showing results (121-130 of 227) with videos related to

Sort By:
Pageof 23
British Journal of Cancer|August 1, 1994
Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidyS Vesalainen, S Nordling, P Lipponen, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 6, 2002
Soluble immunological parameters and early prognosis of renal cell cancer patientsJ P Kallio, T L Tammela, A T Marttinen, et al.
Scandinavian Journal of Urology and Nephrology|April 9, 2001
Hydrophilic versus non-coated catheters for intermittent catheterizationH Hedlund, K Hjelmås, O Jonsson, et al.
The Prostate|August 1, 1995
Nuclear morphometry is of independent prognostic value only in T1 prostatic adenocarcinomasS Vesalainen, P Lipponen, M Talja, et al.
Anticancer Research|March 1, 1995
Results of the primary treatment in T1-3M0 prostatic adenocarcinoma are dependent on tumour biologyS Vesalainen, P Lipponen, S Nordling, et al.
Scandinavian Journal of Gastroenterology|June 1, 1987
Peritoneal lavage combined with volume therapy in porcine hemorrhagic pancreatitis. Effects on hemodynamics, microcirculation, and peritoneal morphologyA Lehtola, M Talja, P Puolakkainen, et al.
British Journal of Cancer|January 1, 1997
Concomitant i.v. and oral clodronate in the relief of bone pain--a double-blind placebo-controlled study in patients with prostate cancerT Kylmälä, T Taube, T L Tammela, et al.
European Journal of Ultrasound : Official Journal of the European Federation of Societies for Ultrasound in Medicine and Biology|June 26, 2001
Kidney ultrasound and Doppler ultrasound findings during and after acute urinary retentionS Mustonen, I O Ala-Houhala, P Vehkalahti, et al.
Urological Research|January 1, 1992
The effect of acute distension on vasoactive intestinal polypeptide (VIP), neuropeptide Y (NPY) and substance P (SP) immunoreactive nerves in the female rat urinary bladderL T Lasanen, T L Tammela, P Liesi, et al.
British Journal of Cancer|May 1, 1995
Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancerT Kylmälä, T L Tammela, L Risteli, et al.
Pageof 23